Back to search

Article

Licensing Microgels Prolong the Immunomodulatory Phenotype of Mesenchymal Stromal Cells

2022-07-05

Abstract excerpt

Mesenchymal stromal cells (MSC) are sensors of inflammation, and they exert immunomodulatory properties through the secretion of cytokines and exosomes and direct cell-cell interactions. MSC are routinely used in clinical trials and effectively resolve inflammatory conditions. Nevertheless, inconsistent clinical outcomes necessitate the need for more robust therapeutic phenotypes. The immunomodulatory properties o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7baa1761-bf53-5835-83ca-94e3c897fac2
DOI
10.1101/2022.07.05.498567
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Licensing Microgels Prolong the Immunomodulatory Phenotype of Mesenchymal Stromal CellsDOI 10.1101/2022.07.05.498567
Licensing microgels prolong the immunomodulatory phenotype of mesenchymal stromal cells.Semantic proximity
The role of cytokine licensing in shaping the therapeutic potential of wharton’s jelly MSCs: metabolic shift towards immunomodulation at the expense of differentiationSemantic proximity
Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint diseaseSemantic proximity
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesSemantic proximity
IL-17 Triggers Invasive and Migratory Properties in Human MSCs, while IFNy Favors their Immunosuppressive Capabilities: Implications for the "Licensing" Process.Semantic proximity
Immunomodulatory potential of cytokine-licensed human bone marrow-derived mesenchymal stromal cells correlates with potency marker expression profileSemantic proximity
“Immunomodulatory nanoparticles elicit antifibrotic monocyte activation to resolve murine pulmonary fibrosis”Semantic proximity
Engineering Mesenchymal Stem Cells to Extend Healthspan: Therapeutic Potential, Challenges, and Future SolutionsSemantic proximity
The Impact of IFN-γ Licensing on Mesenchymal Stromal Cells Mediated Immunoregulation and HLA Class II Expression: Emerging Evidence from In Vitro ResultsSemantic proximity
Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicineSemantic proximity
Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?Semantic proximity
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationSemantic proximity
Select a neighboring publication to make it the new centre.